The potential clinical and fiscal impacts of blood-based methylated Septin9 testing for colorectal cancer screening. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
Phase II propensity-matched controlled trial evaluating metformin as an adjunct to neo-adjuvant, concomitant, and adjuvant temozolomide and hypofractionated-accelerated radiotherapy (M-HART) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results